Nothing Special   »   [go: up one dir, main page]

MA26491A1 - Composes inhibiteurs selectifs de cox-2, anti-inflammatoires et compositions pharmaceutiques les contenant . - Google Patents

Composes inhibiteurs selectifs de cox-2, anti-inflammatoires et compositions pharmaceutiques les contenant .

Info

Publication number
MA26491A1
MA26491A1 MA25059A MA25059A MA26491A1 MA 26491 A1 MA26491 A1 MA 26491A1 MA 25059 A MA25059 A MA 25059A MA 25059 A MA25059 A MA 25059A MA 26491 A1 MA26491 A1 MA 26491A1
Authority
MA
Morocco
Prior art keywords
inflammatory
pharmaceutical compositions
same
compositions containing
inhibitor compounds
Prior art date
Application number
MA25059A
Other languages
English (en)
Inventor
Marie Lundy Kristin
Paul Ricketts Anthony
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MA26491A1 publication Critical patent/MA26491A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
MA25059A 1997-05-05 1998-05-04 Composes inhibiteurs selectifs de cox-2, anti-inflammatoires et compositions pharmaceutiques les contenant . MA26491A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05

Publications (1)

Publication Number Publication Date
MA26491A1 true MA26491A1 (fr) 2004-12-20

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25059A MA26491A1 (fr) 1997-05-05 1998-05-04 Composes inhibiteurs selectifs de cox-2, anti-inflammatoires et compositions pharmaceutiques les contenant .

Country Status (32)

Country Link
EP (1) EP0988034A1 (fr)
JP (1) JP2000513020A (fr)
KR (2) KR20010012300A (fr)
CN (1) CN1255059A (fr)
AP (1) AP9801234A0 (fr)
AR (2) AR011726A1 (fr)
AU (1) AU6932198A (fr)
BG (1) BG103852A (fr)
BR (1) BR9808720A (fr)
CA (1) CA2288759A1 (fr)
DZ (1) DZ2479A1 (fr)
EA (1) EA003696B1 (fr)
GT (1) GT199800063A (fr)
HR (1) HRP980244A2 (fr)
HU (1) HUP0001286A3 (fr)
ID (1) ID21311A (fr)
IL (1) IL132570A0 (fr)
IS (1) IS5220A (fr)
MA (1) MA26491A1 (fr)
NO (1) NO995389L (fr)
NZ (1) NZ500183A (fr)
OA (1) OA11213A (fr)
PA (1) PA8450601A1 (fr)
PE (1) PE72599A1 (fr)
PL (1) PL337003A1 (fr)
SK (1) SK148199A3 (fr)
TN (1) TNSN98059A1 (fr)
TW (1) TW590773B (fr)
UY (1) UY24989A1 (fr)
WO (1) WO1998050033A1 (fr)
YU (1) YU55899A (fr)
ZA (1) ZA983722B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
US6506785B2 (en) 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
AU764872B2 (en) * 1998-10-23 2003-09-04 Merck Frosst Canada & Co. Combination product comprising an E-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
CA2363590A1 (fr) * 1999-03-10 2000-09-14 G.D. Searle & Co. Procede et composition se rapportant a l'administration d'un inhibiteur de la cyclo-oxygenase-2
WO2001034204A1 (fr) * 1999-11-11 2001-05-17 Eli Lilly And Company Produits composes oncolytiques destines au traitement du cancer
EP1283723A2 (fr) * 2000-05-15 2003-02-19 Merck Frosst Canada & Co. Polytherapie faisant appel a un inhibiteur selectif de cox-2 et a un inhibiteur de la thromboxane ainsi que des compositions contenant ceux-ci
RU2003100874A (ru) 2000-06-13 2004-06-27 Вайс (Us) Болеутоляющие и противовоспалительные составы, содержащие ингибиторы циклооксигеназы-2
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
DE60137512D1 (de) 2000-08-07 2009-03-12 Univ Vanderbilt Zusammensetzungen und verfahren zum nachweis und zur quantifizierung von cox-2-aktivität und 2-arachidonylglycerin-metaboliten
US20040209959A1 (en) * 2001-07-16 2004-10-21 Edward Hogestatt Congeners of acetaminophen and related compounds as substrates for fatty acid conjugation and their use in treatment of pain, fever and inflammation
DK1534305T3 (da) 2003-05-07 2007-02-05 Osteologix As Behandling af brusk-/knoglelidelser med vandoplöselige strontiumsalte
MXPA06001288A (es) * 2003-07-31 2006-04-11 Upjohn Co Formulacion dispersable de un agente anti-inflamatorio.
AU2006248645A1 (en) * 2005-05-20 2006-11-23 Pfizer Limited Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands
CN103120653B (zh) 2007-04-04 2015-09-30 希格默伊德药业有限公司 一种口服药物组合物
CA2942083C (fr) 2007-04-26 2019-01-29 Sigmoid Pharma Limited Fabrication de minicapsules multiples
SG176145A1 (en) 2009-05-18 2011-12-29 Sigmoid Pharma Ltd Composition comprising oil drops
JP5911799B2 (ja) 2009-08-12 2016-04-27 シグモイド・ファーマ・リミテッドSigmoid Pharma Limited ポリマーマトリックスおよび油相を含んで成る免疫調節組成物
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
DK3113774T3 (da) 2014-03-06 2022-03-07 Elanco Animal Health Incorporated Sammensætninger af grapiprant og fremgangsmåder til anvendelse deraf
PL3215127T3 (pl) 2014-11-07 2021-05-17 Sublimity Therapeutics Limited Kompozycje zawierające cyklosporynę
US12109218B2 (en) 2014-12-09 2024-10-08 Aratana Therapeutics, Inc. Compositions of grapiprant and methods for using the same
AU2016205145A1 (en) * 2015-01-09 2017-07-13 Jaguar Health, Inc. Methods of treating diarrhea in companion animals
WO2021195346A1 (fr) * 2020-03-25 2021-09-30 Sri International Inhibiteurs de lipoxygénase
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (fr) * 1987-02-03 1993-07-06 Alberto Ferro Solutions de micelles mixtes

Also Published As

Publication number Publication date
ID21311A (id) 1999-05-20
JP2000513020A (ja) 2000-10-03
KR20040004406A (ko) 2004-01-13
NZ500183A (en) 2002-04-26
DZ2479A1 (fr) 2003-02-01
IL132570A0 (en) 2001-03-19
BG103852A (en) 2000-06-30
AR011726A1 (es) 2000-08-30
AP9801234A0 (en) 1999-11-04
HRP980244A2 (en) 1999-02-28
NO995389D0 (no) 1999-11-04
PA8450601A1 (es) 2000-05-24
TNSN98059A1 (fr) 2005-03-15
EP0988034A1 (fr) 2000-03-29
WO1998050033A1 (fr) 1998-11-12
OA11213A (en) 2003-07-14
HUP0001286A3 (en) 2000-12-28
CA2288759A1 (fr) 1998-11-12
AU6932198A (en) 1998-11-27
TW590773B (en) 2004-06-11
CN1255059A (zh) 2000-05-31
GT199800063A (es) 1999-10-26
BR9808720A (pt) 2000-07-11
EA003696B1 (ru) 2003-08-28
HUP0001286A2 (hu) 2000-11-28
EA199900895A1 (ru) 2000-06-26
KR20010012300A (ko) 2001-02-15
UY24989A1 (es) 2001-10-25
IS5220A (is) 1999-10-19
SK148199A3 (en) 2001-09-11
YU55899A (sh) 2003-08-29
PE72599A1 (es) 1999-08-12
AR039628A2 (es) 2005-03-02
ZA983722B (en) 1999-11-04
NO995389L (no) 2000-01-04
PL337003A1 (en) 2000-07-31

Similar Documents

Publication Publication Date Title
MA26491A1 (fr) Composes inhibiteurs selectifs de cox-2, anti-inflammatoires et compositions pharmaceutiques les contenant .
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
MA26548A1 (fr) Compositions pharmaceutiques topiques contenant des derives de resorcinol.
DZ3191A1 (fr) Composés d'indazole et compositions pharmaceutiques inhibant les protéines kinases, et procédés d'utilisation de ceux-ci.
MA26553A1 (fr) Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
BR9710372B1 (pt) composto, e, composiÇço farmacÊutica.
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
MA26537A1 (fr) Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant.
TR199901077A3 (tr) Ispençiyari formülasyonlar.
DZ2686A1 (fr) Formulation pharmaceutique orale à libération pulsée.
FR2732967B1 (fr) 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant
FR2705566B1 (fr) Nouvelles compositions pharmaceutiques.
DZ1916A1 (fr) Composés nouveaux et compostions pharmaceutiques les contenant.
NO20003254D0 (no) Anti-østrogene steroider og farmasøytisk preparat inneholdende samme, samt anvendelse derav
DK1263720T3 (da) Azetidinderivater, fremstilling deraf samt farmaceutiske sammensætninger, der indeholder samme
DZ2516A1 (fr) Composition pharmaceutique en aérosol.
MA26673A1 (fr) Composes pharmaceutiques
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
ATE202472T1 (de) Arzneimittel enthaltend oxaliplatin
DZ2461A1 (fr) Dérivés d'arylkylamines nouveaux et composition pharmaceutiques les contenant.
AU7294098A (en) Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
BR9911871B1 (pt) derivados de ácido fenoxiacético e composições farmacêuticas contendo os mesmos.
MA26486A1 (fr) Aryl- et heteroaryl-thiazolocetohydrazides inhibiteurs de proteases, et compositions pharmaceutiques les contenant .
HK1036974A1 (en) Indole derivatives and medicinal compositions containing the same.
TR199600371A2 (tr) Organosilan bilesiklerinin harmanlari ve bunlarin kullanimi.